These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 20396972)
1. The worst drug rule revisited: mathematical modeling of cyclic cancer treatments. Katouli AA; Komarova NL Bull Math Biol; 2011 Mar; 73(3):549-84. PubMed ID: 20396972 [TBL] [Abstract][Full Text] [Related]
2. Mathematical modeling of cyclic treatments of chronic myeloid leukemia. Komarova NL Math Biosci Eng; 2011 Apr; 8(2):289-306. PubMed ID: 21631131 [TBL] [Abstract][Full Text] [Related]
3. Stochastic modeling of drug resistance in cancer. Komarova N J Theor Biol; 2006 Apr; 239(3):351-66. PubMed ID: 16194548 [TBL] [Abstract][Full Text] [Related]
4. An example of the effects of drug resistance on the optimal schedule for a single drug in cancer chemotherapy. Murray JM IMA J Math Appl Med Biol; 1995; 12(1):55-69. PubMed ID: 7594878 [TBL] [Abstract][Full Text] [Related]
5. Optimal Therapy Scheduling Based on a Pair of Collaterally Sensitive Drugs. Yoon N; Vander Velde R; Marusyk A; Scott JG Bull Math Biol; 2018 Jul; 80(7):1776-1809. PubMed ID: 29736596 [TBL] [Abstract][Full Text] [Related]
6. Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies. Foo J; Michor F PLoS Comput Biol; 2009 Nov; 5(11):e1000557. PubMed ID: 19893626 [TBL] [Abstract][Full Text] [Related]
7. The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling. Gaffney EA J Math Biol; 2004 Apr; 48(4):375-422. PubMed ID: 15052504 [TBL] [Abstract][Full Text] [Related]
8. Evolution of resistance to anti-cancer therapy during general dosing schedules. Foo J; Michor F J Theor Biol; 2010 Mar; 263(2):179-88. PubMed ID: 20004211 [TBL] [Abstract][Full Text] [Related]
9. An elementary approach to modeling drug resistance in cancer. Tomasetti C; Levy D Math Biosci Eng; 2010 Oct; 7(4):905-18. PubMed ID: 21077714 [TBL] [Abstract][Full Text] [Related]
10. On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach. Ledzewicz U; Wang S; Schattler H; Andre N; Heng MA; Pasquier E Math Biosci Eng; 2017 Feb; 14(1):217-235. PubMed ID: 27879129 [TBL] [Abstract][Full Text] [Related]
11. Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs. Lai X; Friedman A J Theor Biol; 2019 Feb; 462():490-498. PubMed ID: 30468760 [TBL] [Abstract][Full Text] [Related]
12. Dosage strategies for delaying resistance emergence in heterogeneous tumors. Vakil V; Trappe W FEBS Open Bio; 2021 May; 11(5):1322-1331. PubMed ID: 33638275 [TBL] [Abstract][Full Text] [Related]
14. The effect of intrinsic and acquired resistances on chemotherapy effectiveness. Menchón SA Acta Biotheor; 2015 Jun; 63(2):113-27. PubMed ID: 25750013 [TBL] [Abstract][Full Text] [Related]
15. Application of mathematical models to metronomic chemotherapy: What can be inferred from minimal parameterized models? Ledzewicz U; Schättler H Cancer Lett; 2017 Aug; 401():74-80. PubMed ID: 28323033 [TBL] [Abstract][Full Text] [Related]
16. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy. Murray JM IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996 [TBL] [Abstract][Full Text] [Related]
20. The influence of toxicity constraints in models of chemotherapeutic protocol escalation. Boston EA; Gaffney EA Math Med Biol; 2011 Dec; 28(4):357-84. PubMed ID: 21471436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]